Publication | Open Access
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut‐specific immune responses
43
Citations
47
References
2022
Year
Oral desensitization therapy with AR101 leads to decreased basophil sensitivity to peanut and reshapes peanut-reactive T effector cell responses supporting its potential as an immunomodulatory therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1